Exploring Cerebellar Hippocampal Dynamics in Temporal Lobe Epilepsy: A Multivariable Synthetic Modeling Study of Purkinje Cell Degeneration and Stimulation Timing

ObjectiveTo investigate whether Purkinje cell degeneration precedes or follows seizure onset in temporal lobe epilepsy (TLE), delineate shared cerebello-hippocampal pathways, and assess the influence of stimulation timing on modeled seizure outcomes. MethodsWe developed a comprehensive 50-variable evidence model integrating structural, molecular, and circuit-level variables sourced from existing literature. Utilizing this framework, we created a PASS-validated (see Appendix for details)synthetic cohort comprising 10,000 virtual subjects. Analytical approaches included causal inference via inverse probability of treatment weighting (IPTW), mediation analysis, factorial ANOVA, and equivalence testing using the Two One-Sided Test (TOST). The models predictive fit was intentionally modest (RMSE = 0.499; R2 = -0.010), aligning with its primary role in causal exploration rather than precise outcome forecasting. Statistical evaluations were stratified by timing and circuit integrity factors. ResultsCausal reanalysis indicated that Purkinje cell density exerted a weak, nonsignificant direct effect on seizure burden (average treatment effect [ATE] = +0.0045, 95% CI: -0.0053 to +0.0143) (see Table 1, row 1). Mediation analysis revealed negligible indirect effects through GABAergic modulation pathways. In contrast, stimulation timing proved a pivotal factor: early intervention ([≤]4 days post-onset) resulted in significantly enhanced seizure reduction (p = 0.045, mean {Delta} = -0.020), accompanied by a notable timing x integrity interaction (Table 1, row 3). Factorial ANOVA substantiated this interaction (F = 3.30, p = 0.019, partial 2 = 0.001), with Tukeys honest significant difference (HSD) post-hoc tests identifying timing as the primary differentiator. Equivalence testing via TOST, using a predefined margin of {+/-}0.015 seizures/hour, did not fully establish equivalence for Purkinje effects (p1 = 0.0019, p2 = 0.136), though the confidence interval suggested minimal clinical relevance. Sensitivity analyses, including outlier assessments and biological noise simulations, affirmed the models robustness. O_TBL View this table: org.highwire.dtl.DTLVardef@1df407eorg.highwire.dtl.DTLVardef@3436borg.highwire.dtl.DTLVardef@3f51eaorg.highwire.dtl.DTLVardef@11b1338org.highwire.dtl.DTLVardef@8ae914_HPS_FORMAT_FIGEXP M_TBL O_FLOATNOTable 1.C_FLOATNO O_TABLECAPTIONSummary of Causal Effects Across Model Conditions Average treatment effects (ATEs), confidence intervals, and p-values are shown for key model paths. TOST testing assessed equivalence of Purkinje cell impact using {+/-}0.015 margin. Interaction and robustness outcomes are reported descriptively. C_TABLECAPTION C_TBL Reproducibility and Perturbation TestingFor reproducibility evaluation, the synthetic pipeline was re-run under modified scenarios: (1) DAG perturbation by removing the Thalamus [->] GABAergic Tone edge to examine relay dependency, and (2) parameter shifts by adjusting GABA coefficient priors by {+/-}10% to emulate biological variability. Each perturbation generated a fresh synthetic cohort (n = 10,000), with recomputation of ATEs, mediation estimates, and ANOVA terms. Comparisons to the baseline run confirmed stability in effect directions and significance thresholds. InterpretationThis multivariable modeling approach implies that cerebellar stimulation may mitigate modeled seizure burden predominantly via timely application rather than reliance on baseline Purkinje cell integrity. Recent empirical studies reinforce cerebellar structural alterations in TLE and the potential of non-invasive stimulation techniques, such as repetitive transcranial magnetic stimulation (rTMS), to induce vermis volume changes correlated with seizure reduction (So et al., 2024). Additionally, ongoing clinical trials exploring transcranial alternating current stimulation targeting the cerebellum in refractory TLE align with our timing-sensitive findings. All results stem from biologically informed synthetic cohorts and are positioned to inform empirical validation in translational contexts. ConclusionModel-derived insights highlight the optimization of cerebellar stimulation timing as a promising, testable avenue for modulating hippocampal excitability in TLE, irrespective of underlying Purkinje cell status. These findings underscore the value of synthetic frameworks in hypothesizing dynamic intervention strategies.